Bridging the gap: Exploring aspirin prophylaxis for preeclampsia prevention in pregnant women with endometriosis

Pegah Rashidian, Sedigheh Hantoushzadeh
In: Journal of Endometriosis and Pelvic Pain Disorders · 2025 · vol. 17(4) , pp. 200–212 · doi:10.1177/22840265251343443 · W4411189998
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This review explores the potential of aspirin prophylaxis to prevent preeclampsia in pregnant women with endometriosis by examining shared pathophysiological mechanisms and advocating for further research.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Preeclampsia (PE) represents a significant contributor to maternal and fetal morbidity and mortality, affecting approximately 2%–8% of pregnancies worldwide. While aspirin prophylaxis has demonstrated efficacy in reducing the risk of PE among high-risk populations, current clinical guidelines do not recognize endometriosis as a risk factor warranting aspirin prophylaxis. Endometriosis, a chronic inflammatory condition affecting approximately 10% of women of reproductive age, has been associated with a heightened risk of hypertensive disorders in pregnancy, including PE. This narrative review investigates the relationship between endometriosis and PE, focusing on shared pathophysiological mechanisms such as systemic inflammation, immune dysregulation, and impaired vascular remodeling. These mechanisms not only underpin the increased risk of PE in women with endometriosis but may also be mitigated through aspirin therapy. This review aims to evaluate the potential protective effect of aspirin in reducing preeclampsia risk in this population, identify gaps and limitations in the existing literature, and justify the need for further research on this association. Furthermore, barriers to the implementation of aspirin prophylaxis in this population will be addressed, alongside recommendations for studies aimed at bridging these gaps to enhance maternal and fetal health outcomes.
Full text 1,975 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

Get full access to this article View all access and purchase options for this article. Data availability statement

References

Supplementary Material Please find the following supplemental material available below. For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with. For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article. Cite Cite Cite Download to reference manager If you have citation software installed, you can download citation data to the citation manager of your choice Information, rights and permissions Information Published In

Keywords

Data availability statement Article versions Authors Authors’ contributions Metrics and citations Metrics Journals metrics This article was published in Journal of Endometriosis and Pelvic Pain Disorders. View All Journal MetricsPublication usage* Total views and downloads: 48 *Publication usage tracking started in December 2016 Publications citing this one Receive email alerts when this publication is cited Web of Science: 0 view articles Opens in new tab Crossref: There are no citing articles to show. Figures and tables Figures & Media Tables View Options Access options If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below: loading institutional access options Alternatively, view purchase options below: Purchase 24 hour online access to view and download content. Access journal content via a DeepDyve subscription or find out more about this option.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-08-05T06:45:03.150373+00:00
License: CC0 · commercial use OK